donate now btn purple

Upcoming Events

Our Supporters

pills in handApril 15, 2020


Please be advised that Depakene (Valproic Acid) is being reported in short supply. The anticipated end date of the shortage is April 21, 2020.


A summary of the manufacturers/shortage status, as reported by Drug Shortages Canada can be found here.

June 4, 2019


Tegretol/Carbamazepine are being reported in short supply. A summary of various manufacturers/shortage status, as reported by, can be found below.


 Brand Name Packaging Size     Satus           Date Created      Date Updated      Reports      Estimated Resolution Date   
TARO-CARBAMAZEPINE CHEWABLE TABLETS 100MG     100 Actual Shortage       2019-05-28 2019-05-31  84968 2019-07-31
TEGRETOL 200MGTEGRETOL 200MG  100 Actual Shortage 2019-03-20 2019-04-23  79017 2019-07-26
TARO-CARBAMAZEPINE  500 Actual Shortage  2017-12-04 2019-04-23  31631 Unknown
TARO-CARBAMAZEPINE  100 Actual Shortage 2018-02-09 2019-04-24  39237 Unknown
SANDOZ-CARBAMAZEPINE CR  100 Resolved 2019-05-07 2019-05-09  83221  
TEVA-CARBAMAZEPINE  100 Resolved 2017-03-13 2019-05-28  983  
TEVA-CARBAMAZEPINE  500 Resolved 2019-04-25 2019-05-28  82410  


If you are taking any of these medications, please consult with your pharmacist about their supply. 

March 4th, 2019


Please be advised regarding a medicine shortage of Synacthen Depot.

This medication is utilized for Infantile Spasms. The anticipated end date of the shortage is June 3, 2019.

Please click here for the Drug Shortage Report for SYNACTHEN DEPOT

July 31st, 2017


Brand name Frisium tablets (DIN 02221799) are being discontinued in Canada. Please see Lundbeck's statement regarding the discontinuation here.


Lundbeck estimates that the remaining supply of Frisium for the Canadian market will be depleted by the end of 2018. This estimate is based current inventory levels and historical usage. The run out date is subject to change if there are unanticipated increases/decreases in demand.


With the advance notice, there is an opportunity to proactively discuss the situation with patients who are stabilized on brand name Frisium and decide when to switch from the branded product to a generic formulation. Patients, their families and healthcare professionals can contact Lundbeck’s Medical Information team at 1-866-880-4636 if they have questions or concerns.


There are two (2) generic products currently marketed in Canada:


 DIN Product Name Company
 02244638            Apo-Clobazam            Apotex Inc.
 02238334 Teva-Clobazam Teva Canada Ltd


Pharmascience Inc has discontinued PMS-Clobazam (DIN 02244474)

Pro Doc Ltée has discontinued Clobazam-10 (DIN 02248454)


To receive email alerts about clobazam shortages or discontinuations:

1. Visit
2. Create an account OR Log in to your existing account
3. After you log in, go to this webpage for the active ingredient CLOBAZAM:
4. Click “Follow” to receive clobazam notifications

 Please take a moment to watch this quick video about drug shortages


Website Designed and Hosted by The Social Business